Back to News
Market Impact: 0.12
Glucose Health Appoints Former Coca-Cola Executive John Duffy As CEO, Succeeding Mark Schaftlein
Source: Nasdaq
Management & GovernanceCompany Fundamentals
Glucose Health, Inc. (GLUC) appointed John Duffy as CEO effective September 1, 2026, succeeding Mark Schaftlein. No financial targets, operating updates, or guidance changes were provided, so near-term market impact is likely limited.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
GLUC0.15
More News
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Penske Automotive agrees to be taken private by Penske, Mitsui
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Blackstone President Jon Gray Bets Big on AI Boom
- What's behind the sell-off in AI neocloud stocks like CoreWeave and Nebius
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’